RxDoctor Payments Data

Samantha Furia, MD

Family Medicine · Elizabeth City, NCNPI 1407057508

Payments from drug & device makers

$1,106in general payments, 2019–2025

Across 66 payments — averaging $16.76 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$206
  • Novo Nordisk$167
  • Amgen$120
  • Pfizer$69
  • Novartis$55
  • Teva Pharmaceuticals USA, Inc.$53
  • plus $435 from 17 others

What the payments were for

  • Food & beverage$1,106100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$1,106 in reported general payments places this provider in the 70th percentile of 3,444 family medicine providers in North Carolina.

See all family medicine providers in North Carolina

Medicare billing

Part B allowed, 2024
$132,830
Medicare patients
456
Services billed
4,765

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Trelegy ElliptaFluticasone/Umeclidin/Vilanter48$41,133
EliquisApixaban34$35,080
JardianceEmpagliflozin21$31,354
XareltoRivaroxaban17$16,778
Repatha SureclickEvolocumab14$12,196
Praluent PenAlirocumab15$11,611
Tresiba Flextouch U-100Insulin Degludec14$6,728
Anoro ElliptaUmeclidinium Brm/Vilanterol Tr12$5,347
Lantus SolostarInsulin Glargine,hum.Rec.Anlog26$3,999
Albuterol Sulfate HfaAlbuterol Sulfate71$3,126
PaxlovidNirmatrelvir/Ritonavir18$2,859
Advair DiskusFluticasone Propion/Salmeterol11$2,627
Omeprazole100$1,249
Duloxetine Hcl60$1,145
Atorvastatin Calcium157$1,139

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
GSKTrelegy Ellipta, Anoro Ellipta$35$46,48060 claims
PfizerEliquis, Paxlovid$69$37,93852 claims
Boehringer IngelheimJardiance$49$31,35421 claims
Johnson & JohnsonXarelto$36$16,77817 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 70th percentile of 3,444 family medicine providers in North Carolina.

Other family medicine in Elizabeth City

See the full list for North Carolina

Where these figures come from

Is this you, or does something look wrong? →